News About: Pharm. Industry
Insecticide of Liquid type speeds up its market growth
While liquid mosquito-repellent leading market growth in insecticide market with great demand, native company, Daewoong pharmaceutical co. and Yuyu industry fight against huge multinational company, which results is b...
Pharmaceutical Manufacturing Circles urge to improve Total Amount Bid system aggravating dumping
Pharmaceutical manufacturing circles in relation to bid system of medical institution insist strongly to restrict total sum bidding and convert into bidding by item.
As medical institution adhere to existing custo...
ACE inhibitors on heavy market competition.
The market share of ACE (Angiotensin II) inhibitor drugs showed about 10% last year out of the total 320 billion won of anti-hypertensive drug markets (including diuretics), and estimated to run up to 20to 30% this ye...
BT industry needs to be invested 10 percent of R&D without delay
It is strongly presented that pharmaceutical manufacturing circles should invest over 10 percent of R&D rate to sales to lead BT(Biotechnology) industry without delay.
In the 21C BT period, pharmaceutical manufact...
Advance of Lotte group into Pharmaceutical industry is near at hand
Lotte Confectionery Co., affiliates of Lotte group, is expected to take over 'IY P&F(ex-Ilyang P&F)', affiliates of Ilyang Pharmaceutical Co., and go into pharmaceutical industry in earnest.
Lotte Confectionery co...
Exclusion of Injection from Medical Program works out its heavy Profits and Loses balancing
In relation to plan to exclude injection from medical program of Government, injection manufacturers reckon its profits and loses of own company and take great pains over preparation of its measure.
Most main injec...
Margin request of the insured medicine never to be accepted
Pharmacies, clinics, hospitals, and pharmaceutical companies will be punished seriously if they request or suggest a margin of the insured medicine.
The Korean Pharmaceutical Manufacturers Association (KPMA) disclo...
Cheiljedang released breast cancer drug, Genexol to market.
Cheiljedang announced that Paclitaxel preparation, the first domestic anti-breast cancer drug, was ready to release its sales on the market, the main ingredient of which was originally developed by Samyang in a massiv...
"Insured Medicine Price should be calculated at '85%'"
Regarding the 'Comprehensive Measures to stabilize the finance of Medical Insurance and settle the system separating the roles of pharmacists and doctors' disclosed by the Government, the Korean Pharmaceutical Manufac...
KFDA approved Daewoong's EGF, a new drug for diabetic ulcer.
The KFDA authorized to manufacture the first new diabetic ulcer drug on May 30, of which Daewoong pharmaceutical company developed for the first in its high quality, purity and closer to the human molecular over the w...
